“Abstract
… Ivermectin has shown its usefulness against SARS COV2, both in treatment and in prophylaxis.
Therefore, this work compiles the characteristics of the group of Health Agents (and their close contacts) from a Buenos Aires Hospital specialized in Infectious Diseases, who resorted to it, as well as the results that were obtained…
Material and Method
In the period between June 1 and December 15, 2020, and in the absence of prophylactic pharmacological measures against SARS COV2, a high number of Health Agents from a Metropolitan Infectious Hospital used - of their own free will - Ivermectin (IVM) to alleviate this deficiency.
In all cases, this drug was used at a rate of 0.2 mg per kilogram of weight, in a weekly dose, for eight weeks, followed by an interval of 4 (four) months of rest...
No infections were recorded among the 162 subjects during the period mentioned at the beginning.
Conclusion
… From the data included in this compilation, it appears that Ivermectin has been an excellent adjuvant method for Personal Protective Equipment, for the prophylaxis of SARS Cov 2 in health personnel and their contacts.
As such, it is not only recommended to extend it to all Health Agents, but also to all vulnerable population groups (geriatric and psychiatric institutes, orphanages, prisons, etc.).”
© 2020 Hirsch RR, et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License